A carregar...

Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells

Continuous oncogenic processes that generate cancer require an on-going treatment approach to eliminate the transformed cells, and prevent their further development. Here, we studied the ability of T cells expressing a chimeric antibody-based receptor (CAR) to offer a therapeutic benefit for breast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Globerson-Levin, Anat, Waks, Tova, Eshhar, Zelig
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015244/
https://ncbi.nlm.nih.gov/pubmed/24572294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2014.28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!